Paediatric Consumer Health in Switzerland
PAEDIATRIC CONSUMER HEALTH IN SWITZERLAND
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Child-specific Medication Is Highly Regulated in Switzerland
Parents Use OTC Medication To Treat Minor Conditions
Parental Cautiousness Expected To Continue Restricting Category Growth
Competitive Landscape
the Category Is Fragmented
Restricted Market Opportunities Force Companies To Withdraw Products
Continued Product Withdrawal Expected To Lower Multinational Presence and Further Limit Choices
Category Data
Table 1 Sales of Paediatric Consumer Health by Category: Value 2013-2018
Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018
Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018
Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018
Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018
Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023
Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023
Executive Summary
Demand Drops for Consumer Health, Leading To A Weaker Performance
High Costs Force Consumers To Find Ways To Save
Leading Brands Maintain Their Top Positions
Online Retailing Is Hit by Stringent Legislation
Consumer Health Set To See Slightly Positive Improvement Over the Forecast Period
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 1 Research Sources
In 2018, paediatric consumer health registered value decline, resulting from Swiss parents’ cautiousness about administering medication to their children. Swiss parents generally consult doctors and give their children prescription medication. Pharmacists also encourage parents to consult a doctor, especially in the case of small children under six years of age. OTC products for children are highly regulated in Switzerland, which results in a restricted number of products on the market. This fac...
Euromonitor International's Paediatric Consumer Health in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.